Sage Journals: Discover world-class research

Open access

Research article

First published 2011-09

Combining Basal Insulin Analogs with Glucagon-Like Peptide-1 Mimetics

Riccardo Perfetti

Diabetes Technology & Therapeutics

Free access

Research article

First published 2007-03

Treating insulin resistance: future prospects

Clifford J Bailey

Diabetes & Vascular Disease Research

Free access

Review article

First published 2014-10

Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making

Gerhard H. Scholz, Holger Fleischmann

Therapeutic Advances in Endocrinology and Metabolism

Open access

Research article

First published 2017-9

Synthesis of a new insulin-mimetic anti-diabetic drug containing vitamin A and vanadium(IV) salt: Chemico-biological characterizations

Abdel Majid A Adam, Ahmed M Naglah, Mohamed A Al-Omar [...]

International Journal of Immunopathology and Pharmacology

Retricted access

Review article

First published 2010-01

The Role of Basal Insulin and Glucagon-Like Peptide-1 Agonists in the Therapeutic Management of Type 2 Diabetes—A Comprehensive Review

Satish K. Garg

Diabetes Technology & Therapeutics

Free access

Correction

First published 2015-2

Erratum to ‘Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making’

Therapeutic Advances in Endocrinology and Metabolism

Retricted access

Review article

First published 2011-07

The Peroxide Dilemma: Opposing and Mediating Insulin Action

Anna A. Szypowska, Boudewijn M.T. Burgering

Antioxidants & Redox Signaling

Retricted access

Other

First published 2005-07

The incretin mimetic,exenatide: a novel treatment option for type 2 diabetes

Catherine A Schnabel

The British Journal of Diabetes & Vascular Disease

Retricted access

Research article

First published 2006-06

Incretin Mimetics and Dipeptidyl Peptidase-IV Inhibitors: A Review of Emerging Therapies for Type 2 Diabetes

David M. Kendall, Dennis Kim, David Maggs

Diabetes Technology & Therapeutics

Free access

Research article

First published 2013-1

Potential Benefits of Cinnamon in Type 2 Diabetes

Molly E. Howard, Nicole D. White

American Journal of Lifestyle Medicine

Search results